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Abstract Rationale: Few studies have examined the ef-
fects of 2,5-dimethoxy-4-(n)-propylthiophenethylamine
(2C-T-7) in vivo. Objectives: 2C-T-7 was tested in a
drug-elicited head twitch assay in mice and in several drug
discrimination assays in rats; 2C-T-7 was compared to the
phenylisopropylamine hallucinogenR(−)-1-(2,5-dimethoxy-
4-methylphenyl)-2aminopropane (DOM) in both assays,
with or without pretreatment with the selective 5-HT2A
antagonist (+)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophe-
nylethyl)]-4-piperidine-methanol (M100907). Finally, the
affinity of 2C-T-7 for three distinct 5-HT receptors was
determined in rat brain. Methods: Drug-elicited head
twitches were quantified for 10 min following administra-
tion of various doses of either 2C-T-7 or R(−)-DOM, with
and without pretreatments of 0.01 mg/kg M100907. In rats
trained to discriminate lysergic acid diethylamide (LSD),
2C-T-7 and R(−)-DOM were tested for generalization. In
further studies, rats were trained to discriminate 2C-T-7
from saline, then challenged with 0.05 mg/kg M100907. In
competition binding studies, the affinity of 2C-T-7 was
assessed at 5-HT2A receptors, 5-HT1A receptors, and 5-
HT2C receptors. Results: 2C-T-7 and R(−)-DOM induced
similar head twitch responses in the mouse that were an-
tagonized by M100907. In the rat, 2C-T-7 produced an in-
termediate degree of generalization (75%) to the LSD cue
and served as a discriminative stimulus; these interoceptive
effects were attenuated by M100907. Finally, 2C-T-7 had
nanomolar affinity for 5-HT2A and 5-HT2C receptors and
lower affinity for 5-HT1A receptors. Conclusions: 2C-T-7
is effective in two rodent models of 5-HT2 agonist activi-
ty and has affinity at receptors relevant to hallucinogen
effects. The effectiveness with whichM100907 antagonizes
the behavioral actions of 2C-T-7 strongly suggests that
the 5-HT2A receptor is an important site of action for this
compound.
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Introduction
The chemical structure of 2,5-dimethoxy-4-(n)-propylthio-
phenethylamine (2C-T-7, Fig. 1, top) places it into the
substituted phenethylamine superfamily of compounds.
This classification encapsulates a variety of drugs of abuse
with differing mechanisms of action, including dopami-
nergic psychostimulants (such as amphetamine), seroto-
nergic hallucinogens (such as mescaline), and mixed-action
“entactogens” [such as 3,4-methylenedioxymethamphet-
amine (MDMA)]. The designation “2C-T-7” originated with
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Alexander Shulgin (Shulgin and Shulgin 1991) and invokes
the two carbon (2C) phenethylamine homologues of pre-
viously synthesized amphetamines which formed the basis
for this drug series, as well as the thio group substitution
(T) on the phenyl ring. The final number in the designation
is not based on any structural properties of the molecule
but refers simply to the series order in which this particular
compound was designed and synthesized.
2C-T-7 was placed temporarily into Schedule I under
the Controlled Substances Act in September of 2002 by
theUnited States Drug Enforcement Administration (Brown
2002), and this placement was made permanent in early
2004 (Leonhart 2004). Despite these aggressive attempts
at regulation, 2C-T-7 remains readily available for pur-
chase via the Internet. Anecdotal reports from human users
posted to Internet sites specializing in the dissemination
of drug information (for example, http://www.erowid.org
and http://www.lycaeum.org) suggest that 2C-T-7 has pro-
found psychedelic actions in man, resulting in some poten-
tial for abuse. For example, an on-line survey conducted by
erowid.org in 2001 garnered 423 valid 2C-T-7 responders,
suggesting that the illicit use of this compound may be
significant. Another recent study reported that 2C-T-7 was
being openly sold in 8-mg tablets at several “smartshops”
across the Netherlands, although it was apparently being
marketed in this form as a “dietary supplement” (de Boer
and Bosman 2004).
The mechanism of action for 2C-T-7 has not been elu-
cidated, although its chemical structure, as well as the
anecdotal reports of its hallucinogenic activity in man,
suggests that serotonin systems, specifically 5-HT2A re-
ceptors (Sadzot et al. 1989), may be involved. In this
regard, the drug-elicited head twitch response (HTR)
(Corne et al. 1963; Corne and Pickering 1967) is a selective
behavioral model for 5-HT2 agonist activity in the rodent,
and several previous studies have established that direct
and indirect 5-HT agonists induce this effect (Peroutka et
al. 1981; Colpaert and Janssen 1983; Green et al. 1983;
Goodwin and Green 1985; Darmani et al. 1990a,b, 1992).
Further, 5-HT2 receptor antagonists selectively block the
HTR (Lucki et al. 1984; Handley and Singh 1986), and the
potency with which they do so is highly correlated with
the antagonist’s affinity for 5-HT2 receptors (Peroutka et
al. 1981; Ortmann et al. 1982).
Similarly, the strong correlation between discriminative
stimuli in nonverbal species and subjective effects re-
ported by humans (Schuster and Johanson 1988; Sanger
et al. 1994; Brauer et al. 1997) allows for a useful char-
acterization of the interoceptive cues produced by psy-
chedelic drugs using drug discrimination procedures in
laboratory rodents. The discriminative stimulus properties
of R(−)-1-(2,5-dimethoxy-4-methylphenyl)-2aminopropane
(DOM, Fig. 1, middle) and lysergic acid diethylamide (LSD,
Fig. 1, bottom) have been extensively investigated in several
different animal species, and it has been shown that, in
agreement with studies in humans, these hallucinogens gen-
eralize with one another (Winter 1978; Glennon et al. 1983a,
b; Fiorella et al. 1995a). Furthermore, antagonist correlation
analysis has determined that the stimulus effects of phe-
nylisopropylamine and indolealkylamine hallucinogens are
mediated by agonist activity at 5-HT2A receptors and mod-
ulated by agonist activity at 5-HT2C receptors (Fiorella et al.
1995b). Recently, 2C-T-7 has been shown to generalize to
the interoceptive cue induced by DOM in rats (Khorana et
al. 2004), although the pharmacological mechanism for this
effect was not explored using antagonist challenges.
Thus, in order to compare potency and effectiveness of
2C-T-7 with a traditional phenylisopropylamine halluci-
nogen, we established dose-effect functions for 2C-T-7
and the structurally similar psychedelic R(−)-DOM in the
HTR assay inmice. Antagonist studies were then conducted
with the selective 5-HT2A antagonist (+)-(2,3-dimethoxy-
phenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-metha-
nol (M100907, formerly MDL100907) in order to gauge
the involvement of 5-HT2A receptors in the HTR induced
by each compound. A parallel series of DD experiments
were conducted in rats in order to characterize the similar-
ity of the discriminative stimulus effects of 2C-T-7 and
R(−)-DOM with those of LSD. The capacity of 2C-T-7
to serve as a discriminative stimulus and the effects of
M100907 on 2C-T-7-appropriate responding were also
tested in a separate group of rats. Finally, binding of 2C-T-7
to 5-HT1A, 5-HT2A, and 5-HT2C receptors was character-
ized in rat brain using a competition binding technique.
Materials and methods
Animals
Male NIH Swiss mice (Harlan Sprague–Dawley Inc., In-
dianapolis, IN) weighing ∼20–30 g were housed 12 an-
Fig. 1 Chemical structures of 2C-T-7 (top), DOM (middle), and
LSD (bottom)
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imals per 44.5×22.3×12.7-cm Plexiglas cage and used in
drug-elicited head twitch experiments. Mice were housed
in a temperature-controlled room at the University of
Michigan that was maintained at an ambient temperature
of 22±2°C at 45–50% humidity. Lights were set to a 12-h
light/dark cycle. Animals were fed with Lab Diet rodent
chow (Laboratory Rodent Diet #5001, PMI Feeds, Inc.,
St. Louis, MO) and water ad libitum until immediately
before testing. Animals were not used in experiments until
at least 2 days after arrival in the laboratory. Each animal
was used only once and was sacrificed immediately after
use.
Male Fischer-344 rats obtained from Harlan Sprague–
Dawley Inc. at an age of ∼6 weeks were used in LSD
discrimination experiments. Rats were housed in pairs with
free access to water in a temperature-controlled room at the
State University of New York at Buffalo under a constant
12-h light/dark cycle (all experiments were conducted
during the light phase). Caloric intake was controlled to
yield a mean body weight of ∼250 g; supplemental feedings
of standard rat chow were provided following experimental
sessions.
All studies were carried out in accordance with the
Declaration of Helsinki and with the Guide for Care and
Use of Laboratory animals as adopted and promulgated
by the National Institutes of Health. Experimental protocols
were approved by the Animal Care and Use Committees
at the University of Michigan or the State University of
New York at Buffalo.
Procedure
Drug-elicited head twitch response in mice
On experimental days, mice were weighed, marked, and
returned to the home cage. Doses were then calculated and
prepared for injection. Individual animals were subse-
quently removed from the home cage, injected i.p. with
saline or 0.01 mg/kg M100907, then placed into a 15.24×
25.40×12.70-cm Plexiglas mouse cage. This antagonist
dose was chosen based upon our previous demonstrations
of its effectiveness against head twitches induced by 4-iodo-
2,5-dimethoxyphenylisopropylamine (DOI) (Fantegrossi
et al. 2004a). Methods for measuring drug-elicited head
twitch behavior have been previously described (Corne et
al. 1963; Corne and Pickering 1967; Boulton and Handley
1973; Fozard and Palfreyman 1979; Green et al. 1983;
Fantegrossi et al. 2004b). For the present experiments,
10 min after the initial injection, mice were injected with
various doses of 2C-T-7, R(−)-DOM, or saline and returned
to the small observation cage. Five minutes after this second
injection, a camera mounted above the observation cage
began recording behavior and continued to do so for 10min.
Videotapes were later scored by two blind observers for
HTR, here defined as a rapid rotational jerk of the head that
is not contiguous with any grooming or scratching be-
haviors. All HTR experiments were conducted in the colony
room at an ambient temperature of 22±2°C, and neither
food nor water was available during the tests.
LSD-like discriminative stimulus effects in rats
Six small animal test chambers (Med-Associates Model
ENV-008), each equipped with a house light and an ex-
haust fan and housed in larger lightproof Malaguard
sound-attenuating cubicles (Med-Associates Model ENV-
022M), were used for these experiments. The chamber
contained two levers mounted on opposite sides of one wall.
Centered between the levers was a dipper that delivered
0.1 ml of sweetened condensed milk diluted 2:1 with tap
water.
Twenty subjects were trained to discriminate LSD (0.1
mg/kg, 15-min pretreatment time, i.p. injection) from sa-
line, as described previously (Fiorella et al. 1995a,b). A
nonresetting fixed ratio 10 (FR10) schedule of reinforce-
ment was employed using the MED-PC version IV be-
havioral programming application. Drug-induced stimulus
control was assumed to be present when, in five consec-
utive sessions, 83% or more of all responses prior to the
delivery of the first reinforcer were on the appropriate
lever. The LSD training dose produced ∼99.5% drug-
appropriate responding. After stimulus control was estab-
lished with the training agents, tests with 2C-T-7 and R
(−)-DOM were conducted once per week in each animal
so long as performance did not fall below the criterion
level of 83% correct responding in any one of the pre-
vious three training sessions. Half of the test sessions
were conducted the day after saline training sessions with
the remainder following LSD training sessions. During test
sessions, no responses were reinforced and the session was
terminated after the emission of ten responses on either
lever. The distribution of responses between the two levers
was expressed as a percentage of total responses emitted on
the drug-appropriate lever. Response rate was calculated for
each session by dividing the total number of responses
emitted on both levers by the elapsed time prior to ten re-
sponses on either lever.
2C-T-7-induced stimulus control in rats
In rats trained with LSD as a discriminative stimulus,
maximum generalization to 2C-T-7 was observed at a dose
of the latter drug of 1.0 mg/kg with minimal effects on
response rate (see Fig. 3). For that reason, a dose of
1.0 mg/kg of 2C-T-7 was chosen for training. The general
procedure was that described above for training with LSD
with the exception that a pretreatment time of 45 min was
used. The pretreatment time was based on the observation
in LSD-trained subjects that maximum generalization of
LSD to 2C-T-7 occurs after 45 min (see Fig. 3). In a group
of ten rats, criterion performance was reached after a mean
of 33 sessions (SE=2). To establish the role of 5-HT2A
receptors in the stimulus effects of 2C-T-7, 0.05 mg/kg
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M100907 was injected i.p. 15 min before 2C-T-7, i.e.,
60 min before testing. This dose of M100907 has pre-
viously been used by our lab to block stimulus control by
LSD (Winter et al. 2004).
Complete generalization of a training drug to a test drug
is said to be present when (1) a mean of 80% or more of
all test responses occurs on the drug-appropriate lever; (2)
there is no statistically significant difference between the
response distributions of the training drug and the test
drug; and (3) there is a statistically significant difference
between the response distributions of the test drug and
saline control sessions. An intermediate degree of gener-
alization is defined as being present when response distri-
butions after a test drug are less than 80% drug appropriate
and are significantly different from both training condi-
tions. Finally, when the response distribution after a test
drug is not statistically significantly different from that in
saline control sessions, an absence of generalization of the
training drug to the test drug is assumed. Similar criteria are
applied to the definitions of full, partial, and no antago-
nism. Thus, full antagonism is assumed to be present when
(1) less than 20% of all test responses are on the training
drug-appropriate lever; (2) there is no significant difference
between the response distributions in the test of antagonism
and the saline control; and (3) there is a statistically sig-
nificant difference between the response distributions of
the test drug alone and in combination with the antagonist.
Competition binding in rat brain
Frontal cortex (5-HT2A receptors), hippocampus (5-HT1A
receptors), and brain stem (5-HT2C receptors) were har-
vested from male CDF rats (Charles Rivers Laboratories)
and homogenized (Dounce tissue grinder) in 50 mM Tris–
HCl (pH 7.4). Homogenates were centrifuged at 40,000×g
for 15 min at 4°C, and the resulting pellets were resus-
pended in the Tris buffer and stored at −80°C. On the day
of the assays, tissue samples were thawed and centrifuged
at 40,000×g for 15 min at 4°C. The resulting pellets were
resuspended in 30 ml warm 50 mM Tris–HCl (pH 7.4) and
incubated for 10 min at 37°C to remove endogenous se-
rotonin. Samples were again centrifuged at 40,000×g for
15 min at 4°C. Final resuspension of the pellets (frontal
cortex, 6.7 mg/ml; hippocampus, 5 mg/ml; brain stem,
13.3 mg/ml) was carried out in Tris assay buffer (50 mM
Tris–HCl, pH 7.4, containing 4 mM MgCl2, 10 μM par-
gyline, and 0.1% ascorbate).
[3H]8-OH-DPAT binding assays were carried out for
30 min at 37°C in a final volume of 0.5 ml Tris assay
buffer containing 1 nM radioligand (129 Ci/mmol; Perkin-
Elmer, Boston, MA), appropriate drugs, and hippocampal
membranes (2 mg wet weight/tube). [3H]Ketanserin bind-
ing assays were carried out for 30 min at 30°C in a final
volume of 0.5 ml Tris assay buffer containing 1.5 nM
radioligand (88 Ci/mmol; Perkin-Elmer), 100 nM prazosin
to prevent binding to α1-adrenergic receptors, appropriate
drugs, and frontal cortical membranes (2 mg wet weight/
tube). [3H]Mesulergine binding assays were carried out for
45 min at 37°C in a final volume of 0.5 ml Tris assay
buffer containing 2 nM radioligand (77 Ci/mmol; Amers-
ham Biosciences), 100 nM spiperone to prevent binding
to 5-HT2A and dopamine D2 receptors, appropriate drugs,
and membranes from the brain stem (4 mg wet weight/
tube). Reactions were terminated by rapid vacuum fil-
tration (Brandel harvester) through GF/B glass fiber filters
presoaked in 0.1% polyethylenimine. Filters were washed
twice with cold 50 mM Tris–HCl (pH 7.4), and the amount
of bound radioactivity was measured by scintillation spec-
trophotometry. Nonspecific binding was defined as the
difference in the amount of radioligand binding in the ab-
sence and presence of either 10μM5-HT ([3H]8-OH-DPAT
binding), 20 μM 5-HT ([3H]mesulergine binding), or 100
μM cinanserin ([3H]ketanserin binding).
Data analysis
Data from the HTR experiments are presented as mean±
SEM and were compared to values obtained from equi-
volume saline controls using one-way ANOVA and Tukey’s
post hoc tests. These statistical tests were performed using
commercially available software, and significance was
judged at P<0.05. Drug discrimination data are expressed
as percent drug-appropriate responding, which is the num-
ber of responses emitted on the drug-appropriate lever as
a percentage of the total number of responses emitted. Re-
sponse rates are expressed as the number of responses per
minute, calculated for each session by dividing the total
number of responses emitted (prior to the emission of ten
responses on either lever) by elapsed time. Data for any
subjects failing to emit ten responses within the constraints
of the 10-min test session were not considered in the cal-
culation of the percent drug-appropriate responding but
were included in the analysis of response rates. General-
ization was said to occur if 80% or more of the responses
were on the drug-appropriate lever. The statistical sig-
nificance of the generalization of LSD to 2C-T-7 in rats
trained with LSD and the antagonism of 2C-T-7 by
M100907 in rats trained with 2C-T-7 was determined using
one-way ANOVA to compare the two training conditions
with 2C-T-7 and with 2C-T-7 in the presence of M100907,
respectively. Subsequent multiple comparisons were made
by the method of Student–Newman–Keuls. Differences
were considered to be statistically significant if the prob-
ability of their having arisen by chance was <0.05. All
analyses were conducted using SigmaStat 2.03 for Win-
dows (Jandel Scientific Software, San Rafael, CA). Control
data were repeated for each comparison and statistical
analyses were applied using the appropriate control ses-
sions. However, for purposes of clarity, mean values for
control data are shown in all figures. Binding data were




(+)-LSD, R(−)-DOM, and 2C-T-7 were supplied by the
National Institute on Drug Abuse (Research Technology
Branch, Research Triangle Park, NC) and dissolved in 0.9%
physiological saline solution. M100907 was synthesized
at Laboratory of Medicinal Chemistry at the National In-
stitutes of Diabetes, Digestive and Kidney Disorders at the
National Institutes of Health (Bethesda, MD) and dissolved
in sterile water and 0.5 N HCl. All injections were admin-
istered i.p. at a volume of 1.0 ml/kg (rats) or 1.0 ml/100 g
(mice).
Results
Drug-elicited head twitch response in mice
2C-T-7 induced a dose-dependent HTR in mice, producing
a maximum of ∼16 twitches in 10 min at a dose of 1.0 mg/
kg (Fig. 2, left panel, closed circles). Doses of 1.0 and
3.0 mg/kg 2C-T-7 elicited significantly more head twitch
behavior than did saline (q=12.078 for 1.0 mg/kg, q=6.650
for 3.0 mg/kg; P<0.05 for both doses). Pretreatment with
0.01 mg/kg M100907 shifted the 2C-T-7 HTR curve down
and to the right (Fig. 2, left panel, open triangles). Fol-
lowing antagonist pretreatment, 2C-T-7 doses of 3.0 and
10.0 mg/kg induced significantly more head twitch behav-
ior than did saline (q=13.282 for 3.0 mg/kg, q=5.481 for
10.0 mg/kg; P<0.05 for both doses). Similar effects were
obtained with the phenylisopropylamine hallucinogen R
(−)-DOM (Fig. 2, right panel). Doses of 1.0 and 3.0 mg/kg
R(−)-DOM elicited significantly more head twitch behav-
ior than did saline (q=6.548 for 1.0 mg/kg, q=4.688 for
3.0 mg/kg; P<0.05 for both doses). Following antagonist
pretreatment, all R(−)-DOM doses tested induced signif-
icantly more head twitch behavior than did saline (q=
6.095 for 1.0 mg/kg, q=7.850 for 3.0 mg/kg, and q=4.248
for 10.0 mg/kg; P<0.05 for all three doses). Both com-
pounds were comparable in terms of potency and effec-
tiveness in the drug-elicited head twitch assay.
LSD-like discriminative stimulus effects in rats
Rats trained to discriminate 0.1 mg/kg LSD from saline
performed with a high degree of precision on subsequent
testing. Indeed, the training dose of LSD engendered al-
most 100% drug-appropriate responding, whereas saline
occasioned essentially no LSD-appropriate responding
(Fig. 3, top left panel). LSD partially generalized to 2C-T-
7 in a dose-dependent manner, occasioning a maximum of
∼75% drug-appropriate responding at doses of 1.0 mg/kg
[F(7,2)=29.487; P<0.001] and 3.0 mg/kg [F(4,2)=19.136;
P<0.001] (Fig. 3, top left panel). Direct suppressant effects
on response rates were observed at all 2C-T-7 doses tested
(Fig. 3, top right panel), and responding was almost com-
pletely eliminated at 3.0 mg/kg 2C-T-7, preventing the
testing of higher doses for LSD-like effects.
Similar to 2C-T-7, R(−)-DOM also occasioned LSD-
like responding at a dose of 0.3 mg/kg; these stimulus
effects were observed within 15 min postinjection and re-
mained apparent at 45 min postinjection (Fig. 3, bottom
left panel, open diamonds). The time course for the dis-
criminative effects of 2C-T-7 (Fig. 3, bottom left panel,
closed squares) was similar to that of R(−)-DOM, al-
though 2C-T-7 may have a somewhat slower onset in the
rat.
2C-T-7-induced stimulus control in rats
Rats trained to discriminate 1 mg/kg 2C-T-7 from saline
performed in an almost completely drug-appropriate man-
ner when tested with the training dose, and 2C-T-7-appro-
priate responding decreased in a dose-dependent manner
when rats were injected with lower test doses (Fig. 3,
bottom right panel, closed squares). Consistent with results
Fig. 2 Effects of 2C-T-7 (left) and R(−)-DOM (right) on head
twitch behavior in mice treated with M100907 or saline. Each point
represents the mean±SEM (n=6 mice per dose). Abscissae: 2C-T-7
or R(−)-DOM dose (mg/kg, i.p.). Ordinates: Mean head twitches/
10 min. Asterisks indicate significant differences from saline controls
(P<0.05) by Student’s one-sample t-test
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from the head twitch experiments, 0.05 mg/kg M100907
effectively antagonized the discriminative cue induced by
1 mg/kg 2C-T-7, as drug-appropriate responding fell to
saline-like levels following M100907 injection (Fig. 3, bot-
tom right panel, open square) [F(7,2)=327.802; P<0.001].
Competition binding in rat brain
2C-T-7 has nanomolar affinity for 5-HT2A and 5-HT2C
receptors and lower affinity for 5-HT1A receptors. The
affinity of 2C-T-7 for 5-HT2A receptors is equivalent to
that of R(−)-DOM and R(−)-DOI. Because the present
behavioral results strongly suggest an involvement of 5-
HT receptors in the effects of 2C-T-7, the affinity of this
compound at 5-HT2A, 5-HT2C, and 5-HT1A receptors was
determined. The equilibrium dissociation constant (KI) for
2C-T-7 at the 5-HT2A receptor, as measured using [
3H]
ketanserin, was 120 nM (pKI=6.92). By way of compar-
ison, theKI for (−)-DOI at the 5-HT2A receptor was 141 nM
(pKI=6.85), whereas the KI for (−)-DOM at this site was
513 nM (pKI=6.29). TheKI for 2C-T-7 at 5-HT2C receptors,
which was determined using [3H]mesulergine, was 39 nM
(pKI=7.41). Binding affinity of 2C-T-7 at the 5HT1A re-
ceptor, as measured using [3H]8-OH-DPAT, was appre-
ciably lower with a KI of 1.17 μM (pKI=5.93). Binding
affinities for 2C-T-7 at these three 5-HT receptors are
summarized in Table 1.
Fig. 3 Upper panels: discriminative stimulus (left) and rate-altering
(right) effects of 2C-T-7 (squares) in rats discriminating between
0.1 mg/kg LSD (triangle) and saline (inverted triangles). Ordinates:
average percentage of responses on the LSD-associated lever (left)
or rate of lever pressing in responses/min (right). Abscissae: dose in
mg/kg body weight. Bottom left panel: comparison of the time
course of discriminative stimulus effects of 1.0 mg/kg 2C-T-7 and
0.3 mg/kg R(−)-DOM in rats discriminating between 0.1 mg/kg
LSD and saline. Ordinate: as described in upper left panel. Abscissa:
time (min) after 2C-T-7 or R(−)-DOM injection. Bottom right panel:
discriminative stimulus effects of 2C-T-7 in rats trained to discrimi-
nate 1 mg/kg 2C-T-7 from saline. Filled squares represent control
rats; open squares represent rats treated with 0.5 mg/kg M100907
15 min prior to testing. Ordinate: average percentage of responses on
the 2C-T-7-associated lever. Abscissa: dose in mg/kg body weight














Binding of 2C-T-7 to the various serotonin receptors was carried out
as described in Materials and methods. For comparative purposes,
affinity of the 5-HT2A receptor for R(−)-DOM and (−)-DOI was
also determined (see Results). Data are expressed as the negative
log of the equilibrium dissociation constant (pKI) and are presented
as mean±SEM of three to eight separate experiments. Equilibrium
dissociation constants, KI, are presented in the parentheses
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Discussion
The presently reported results suggest that 2C-T-7 is be-
haviorally active in two rodent models of hallucinogen
effects. The capacity of this compound to induce the head
twitch response in the mouse, to engender hallucinogen-
like discriminative stimulus effects in the rat, and the
disruption of both of these effects by prior injection of
M100907 imply that a primary site of action for 2C-T-7 is
the 5-HT2A receptor. This receptor has previously been im-
plicated in the mediation of hallucinogen effects for the
ergoline (LSD-like), indolealkylamine (dimethyltryptamine-
like), and phenylisopropylamine (mescaline-like) halluci-
nogens (Sadzot et al. 1989; Aghajanian and Marek 1999;
Nichols 2004). The similar potencies and efficacies of
2C-T-7 and the more traditional phenylisopropylamine hal-
lucinogen R(−)-DOM across both assays are notable and
comport well with the finding (from the presently reported
binding studies) that the affinities of both of these com-
pounds for the 5-HT2A receptor in rat brain homogenates
are identical.
The observation of drug-elicited behaviors in mice can
be immensely helpful in the initial characterization of the
pharmacological actions of new compounds in vivo. For
instance, the Straub tail reaction (contraction of the sacro-
coccygeus muscle, resulting in erection of the tail) is
readily observed following administration of μ opioids,
and it has been suggested that observation of this behav-
ior is a sufficient determinant of opioid activity in mice
(Aceto et al. 1969). However, the effects most character-
istic of the hallucinogens (such as distortions, intensifica-
tions and mixing of the senses, alterations in the perception
of the passage of time, etc.) are largely unobservable, even
in the human. Nevertheless, the induction of a head twitch
response in rodents seems to be a common property of the
hallucinogenic drugs, and there is now general agreement
that this behavior is mediated by 5-HT2A receptors (Dave et
al. 2002; Dursun and Handley 1996; Schreiber et al. 1995).
This is not to suggest that all drugs inducing the head
twitch response are hallucinogenic. Indeed, head twitches
are induced by various serotonergic, but not hallucino-
genic, agents (i.e., Green et al. 1983; Darmani 1998). Thus,
the induction of a head twitch response should not be taken
as prima facie evidence for hallucinogenic effects without
the further study of a given compound’s subjective effects.
In this regard, stimulus control induced by a given drug
is often found to correlate closely with the subjective ef-
fects of that drug in humans (Schuster and Johanson 1988;
Sanger et al. 1994; Brauer et al. 1997). Thus, for example,
it is expected that morphine-trained rats will generalize
to other drugs whose morphine-like effects have been
established in human subjects. Conversely, if a drug of
unknown subjective properties fully mimics morphine in
morphine-trained rats, we may predict with some con-
fidence that the drug will be morphine-like in humans. In
further contrast with the opiates, a class of drugs with es-
tablished medical uses, hallucinogens are generally illegal
and, with notable exceptions (e.g., Strassman et al. 1996;
Vollenweider 1998), are at the present time seldom studied
in controlled settings. Of necessity, much of our informa-
tion regarding the effects of newer hallucinogens is largely
anecdotal in nature. Nonetheless, accounts of the effects of
2C-T-7 in human subjects by Shulgin and Shulgin (1991),
as well as those posted online, leave little doubt as to the
hallucinogenicity of this compound. Based upon those re-
ports and the previously described generalization of LSD in
LSD-trained rats to R(−)-DOM (Winter and Rabin 1988)
and vice versa (Glennon et al. 1983a,b), we would expect
2C-T-7 to substitute for LSD. The data of Fig. 3 only
partially fulfill that prediction. It is seen that a maximum of
75% LSD-appropriate responding followed the adminis-
tration of doses of 2C-T-7 of 1.0 and 3.0 mg/kg with all
doses of 2C-T-7 producing significant suppression of the
rate of responding relative to that of both training con-
ditions. Suppression of responding precluded the testing
of higher doses of 2C-T-7. The time course for 2C-T-7
and the related phenethylamine hallucinogen, R(−)-DOM,
in LSD-trained rats is quite similar (Fig. 3) but with the
suggestion of a somewhat slower onset and more rapid
decline for 2C-T-7.
We are unaware of previous attempts to train 2C-T-7 as
a discriminative stimulus. In the only previous report of
the stimulus effects of 2C-T-7, rats trained with SR(±)-
DOM generalized completely to 2C-T-7, but rats trained
with cocaine or racemic 3,4-methylenedioxymethamphet-
amine (MDMA) did not (Khorana et al. 2004). In the
present study, stimulus control was readily established
after a mean of 33 sessions at a dose of 1.0 mg/kg using a
pretreatment time of 45 min. The rate of acquisition of
stimulus control by 2C-T-7 under these conditions may be
compared with that for LSD. In a group of six F-344 rats
recently trained in our laboratory using a dose of LSD of
0.1 mg/kg (i.p.) and a 15-min pretreatment time, a mean
of 22 (SEM=1) sessions was required to reach criterion
performance with a rate of lever-press responding of 27
(SEM=6) per minute. In contrast with the modest dif-
ference between the number of sessions required to reach
criterion performance, the training dose of 2C-T-7 is clearly
rate suppressant relative to LSD (Fig. 3). However, like
LSD, 2C-T-7-induced stimulus control is completely antag-
onized by the 5-HT2A-selective antagonist,M100907 (Fig. 3;
Winter et al. 2004). The data of Table 1 indicate that 2C-T-7
has nanomolar affinity for 5-HT2A and 5-HT2C receptors
and a lower affinity for 5-HT1A receptors. The affinity of
2C-T-7 for 5-HT2A receptors is equivalent to that of R(−)-
DOM. These binding data are completely compatible with
the behavioral effects of 2C-T-7 observed in the present
studies.
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